BioPharma Dive - Latest News

Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Mar 3, 2025 - 18:08
 0
Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Callio Therapeutics is launching with an ADC technology and programs licensed from Singapore-based antibody drug developer Hummingbird Bioscience.

Read More

Tags:

Previous Article

‘Two-Year-Olds Must Carry Their Own Bags!’ American Airlines Gate Agent’s Fake R...

Next Article

STAT+: How DOGE is hitting CMS, and another go with transparency

Related Posts

2Seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M

2Seventy bio, Bluebird’s cell therapy spinout, sells to...

Mar 11, 2025  0

FDA meeting on flu vaccine composition is canceled

FDA meeting on flu vaccine composition is canceled

Feb 27, 2025  0

Device industry scrambles amid concern FDA layoffs will cause delays

Device industry scrambles amid concern FDA layoffs will...

Feb 20, 2025  0